Chinese Influenza Weekly Report

Similar documents
Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Chinese Influenza Weekly Report

Surveillance Overview

RESPIRATORY VIRUS SURVEILLANCE REPORT

Influenza Global Epidemiologic Update

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 26, 2018

Influenza Surveillance Summary: Denton County Hospitals and Providers 17.51% 15.95% 10.94% 7.41% 9.01% 8.08%

Seasonal Influenza Report

Influenza Situation Update

Seasonal Influenza Report

Seasonal Influenza Report

Week 11: March 11 to March 17, 2018

Week 15: April 8 to April 14, 2018

Influenza Surveillance in Ireland Weekly Report Influenza Week (11 th 17 th December 2017)


Influenza Surveillance in Ireland Weekly Report Influenza Week (22 nd 28 th January 2018)

GIHSN-China s experience & Results of season Beijing, China

Summary. Week 11/2017 (13 19 March 2017) Season overview

Summary. Week 13/2018 (26 31 March 2018) season overview

Questions and Answers

NC IMMUNIZATION COALITION FLU THEN AND NOW NC DHHS COMMUNICABLE DISEASE BRANCH ANITA VALIANI, MPH AUGUST 1, 2018

Summary. Week 15/2018 (9 15 April 2018) season overview

Summary. Week 4/2018 (22 28 January 2018) season overview

Influenza Surveillance in Ireland Weekly Report Influenza Week (12 th 18 th March 2018)

MEETING THE STANDARDS: FDA MANDATORY RAPID INFLUENZA DETECTION TEST (RIDTs) RECLASSIFICATION

Influenza Situation Update

Community and Hospital Surveillance

Influenza Situation Update

Influenza and other Respiratory Viruses Update

Seasonal Influenza Report

Seasonal Influenza Report

Influenza Surveillance in Ireland Weekly Report Influenza Weeks 13 & (26 th March 8 th April 2018)

November 5 to 11, 2017 (Week 45)

Western Pacific Regional Office of the World Health Organization.

Influenza surveillance summary

Influenza Update N 159

Influenza Update N 157

December 3 to 9, 2017 (Week 49)

Western Pacific Regional Office of the World Health Organization

Bi-weekly Influenza Situation Update

REPORT. Early risk assessment: What to expect of the 2017/18 influenza season in Norway


Influenza Prevention Update

Centers for Disease Control and Prevention U.S. INFLUENZA SEASON SUMMARY*

Table 1: Summary of Texas Influenza (Flu) and Influenza-like Illness (ILI) Activity for the Current Week Texas Surveillance Component

Influenza Surveillance in Ireland Weekly Report Influenza Week (12 th 18 th November 2018)

Influenza Situation Update

Influenza Situation Update

WEEKLY INFLUENZA REPORT

Influenza Surveillance in Ireland Weekly Report Influenza Week (1 st 7 th October 2018)

Alberta Health. Seasonal Influenza in Alberta. 2012/2013 Season. Surveillance and Assessment Branch. November Government of Alberta 1

British Columbia Influenza Surveillance Bulletin

Update on Influenza Vaccines, the Influenza Season, and the Impact of Vaccination on Influenza Disease Burden

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 4, 2019

ARIZONA INFLUENZA SUMMARY

Austin Public Health Epidemiology and Disease Surveillance Unit. Travis County Influenza Surveillance

Summary: Increasing Activity

Main conclusions and options for response

Influenza Weekly Surveillance Bulletin

Ontario Respiratory Pathogen Bulletin I

WEEKLY INFLUENZA REPORT

Global Influenza Virus Surveillance and WHO Influenza Vaccine Virus Recommendations for the Northern Hemisphere Influenza Season

Influenza Situation Update

Influenza Activity Update

British Columbia Influenza Surveillance Bulletin Influenza Season , Number 23, Weeks August 13 to September 23, 2017

Influenza Update N 176

Summary: Low and Decreasing Activity

Summary: Low activity

Summary: Low activity

Weekly Influenza Report

Alberta Health. Seasonal Influenza in Alberta. 2016/2017 Season. Analytics and Performance Reporting Branch

Weekly Influenza Report

Summary: High Activity

Incorporating virologic data into seasonal and pandemic influenza vaccines

Texas Influenza Summary Report, Season (September 28, 2008 April 11, 2009)

Local Influenza Surveillance Bulletin Released October 31, 2016

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Annual Epidemiological Report DRAFT

Summary: Decreasing. Since Sept. 1, 2017: Hospitalizations: 363 ICU* admissions: 26 Deaths: 32

WEEKLY INFLUENZA REPORT

Summary: Increasing Activity

Summary: High Activity

Risk assessment of seasonal influenza - Update, EU/EEA, January 2017

Week 43 (Oct , 2016)

Update on influenza monitoring and vaccine development

Influenza Activity in Indiana

Weekly Influenza Report

ARIZONA INFLUENZA SUMMARY

MA Adult Immunization Coaltion Flu Update September 28, 2016

Weekly Influenza & Respiratory Illness Activity Report

Influenza Weekly Surveillance Bulletin

Low Influenza Activity

Summary: Sustained Influenza B Activity

Centers for Disease Control and Prevention U.S. INFLUENZA SEASON SUMMARY*

Transcription:

National Institute for Viral Disease Control and Prevention, China CDC Chinese Weekly Report (All data are preliminary and may change as more reports are received) Summary During week 17, influenza activity in both southern and northern provinces was at inter-seasonal levels, only a few influenza viruses can be detected, the majority were A(H1N1)pdm09. Among influenza viruses antigenically characterized by CNIC since October 1st, 2017, 239(91.9%) influenza A(H1N1)pdm09 viruses were characterized as A/Michigan/45/2015-like; 116(32.3%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(EGG)-like, 324(90.3%) influenza A(H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(CELL)-like; 106(53.8%) influenza B/Victoria viruses were characterized as B/Brisbane/60/2008-like; 527(97.2%) influenza B/Yamagata viruses were characterized as B/Phuket/3073/2013-like. Among the influenza viruses tested by CNIC for antiviral resistance analysis since October 1st, 2017, all influenza A(H1N1)pdm09 and A(H3N2) viruses were resistant to adamantine; All influenza A(H1N1)pdm09, A(H3N2) and B viruses were sensitive to neuraminidase inhibitors. 1

Outbreak Surveillance During week 17(Apr 23 rd Apr 29 th, 2018), there were 2 outbreaks reported nationwide, 1 of them was A(H1N1)pdm09, 1 of them was not obtained testing result. Surveillance of outpatient or emergency visitss for -like Illness (ILI) During week 17, the percentage of outpatient or emergency visits for ILI (ILI %) at national sentinel hospitals in south China was 3.6%, same as the last week (3.6%), higher than the same week of 2015-2017(2.9%, 3.5%, 3.1% ). (Figure 1) Figure 1. Percentage of Visits for ILI at Sentinel Hospitals in South China (2015-2019) During week 17, ILI% at national sentinel hospitals in north China was 2.3%, lower than last week and the same week of 2015-2017(2 2.4%, 2.4% %, 2.5%, 2.5%). (Figure 2) 2

Figure 2. Percentagee of Visits for ILI at Sentinel Hospitals in North China (2015-2019) Virologic Surveillance During week 17, influenza network laboratories tested 5036 specimens, of which 145(2.9%) were positive for influenza, influenza A and influenza B viruses were 107(73.8%) and 38(26.2% %), respectively (Table 1). During week 17, the percentage of specimens that were tested positive for influenza in south China was 3..1%, which was lower than the previous week (4.1%) (Figure 3). During week 17, the percentage of specimens that were tested positive for influenza in north China was 2..2%, which was similar to the previous week (3.7%). (Figure 4). Table 1 Laboratory Detections of ILI Specimens (Week 17, 2018) Week 17 South China North China Total No. of specimens tested 3847 1189 5036 No. of positive specimens (%) 119(3.1%) 26(2.2%) 145(2.9% %) A 93(78.2%) 14(53.8%) 107(73.8% %) A(H3N2) 4(4.3%) 1(7..1%) 5(4.7%) 3

A(H1N1) )pdm09 89(95.7%) 13(92.9%) 102(95.3% %) A (subtype not determined) 0( (0) B 26(21.8%) 12(46.2%) 38(26.2% %) B (lineage not determined) 0( (0) Victoria 2(7.7%) 4(33.3%) 6(15.8% ) Yamagata 24(92.3%) 8(66.7%) 32(84.2% %) Figure 3. Positive Testss Reported by Southern Network Laboratories (Week 14, 2017 ) Note: Analysis in this part was based on the test results of network laboratories. If it weree not consistent with the results of CNIC confirmation, the results of CNIC confirmation were used. 4

Figure 4. Positive Testss Reported by Northern Network Laboratories (Week 14, 2017 ) Note: Analysis in this part was based on the result of network laboratories. If it were not consistent with the results of CNIC confirmation, the results of CNICC confirmation were used. Antigenic Characterization Since October 1 st, 2017, 239(91.9%) influenza A(H1N1)pdm09 viruses were characterized as A/Michigan/45/2015-like; 116(32.6%) influenza A( (H3N2) viruses were characterized as A/Hong Kong/4801/2014 (H3N2)(EGG)-like, 324(90..3%) influenza A(H3N2) viruses weree characterized as A/Hong Kong/4801/2014 (H3N2)(CELL)-like; 106( (53.8%) influenza B/Victoria viruses were characterized as B/Brisbane/60/ /2008-like; 527(97.2%) influenza B/Yamagata viruses were characterized as B/Phuket/ /3073/2013-like. Antiviral Resistance Since October 1 st, 2017, among the influenza viruses ested by CNIC for antiviral resistance, all influenza A( (H1N1)pdm09 and A(H3N2) viruses were resistant to adamantine; All influenza A(H1N1)pdm09, A(H3N2) and B viruses were sensitivee to neuraminidase inhibitors. H7N9 case report Since the notification of human infection with novel reassortant influenza 5

National Institute for Viral Disease Control and Prevention, China CDC A(H7N9) virus on 31 March 2013, in total 1564 laboratory-confirmed cases have been reported to WHO. Among them, 32 cases were infected with HPAI A(H7N9) virus, which have mutations in the hemagglutinin gene indicating a change to high pathogenicity in poultry. These 32 cases are from Taiwan (the case had travel history to Guangdong), Guangxi, Guangdong, Hunan, Shaanxi, Hebei, Henan, Fujian, Yunnan provinces, with illness onset date before October 2017. No increased transmissibility or virulence to human case was detected in the HPAI A(H7N9) virus. 6